| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.06. | Agios Pharmaceuticals, Inc.: Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress | 95 | GlobeNewswire (Europe) | - ENERGIZE is the First Study to Demonstrate Efficacy of an Oral Treatment for Non-Transfusion-Dependent Alpha- and Beta-Thalassemia - - Additional ENERGIZE Poster Presentation Highlights Improvements... ► Artikel lesen | |
| 15.06. | F. Hoffmann-La Roche Ltd: Roche's Phase III STARGLO study demonstrates Columvi significantly extends survival in people with relapsed or refractory diffuse large B-cell lymphoma | 805 | GlobeNewswire (Europe) | The study met its primary endpoint of overall survival with a 41% reduction in the risk of death in people with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) treated with Columvi... ► Artikel lesen | |
| 15.06. | Parks! America, Inc.: Parks! America Announces Leadership Transition Plan | 173 | GlobeNewswire (Europe) | Pine Mountain, GA, June 14, 2024 (GLOBE NEWSWIRE) -- Parks! America, Inc. (OTCPink: PRKA)(the "Company" or "Parks! America"), a leading owner and operator of drive through safari parks, today announced... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| SUPER MICRO COMPUTER | 4.007 |
| EVOTEC | 3.195 |
| TUI | 2.819 |
| NVIDIA | 2.769 |
| BAYER | 2.667 |
| NEL | 2.485 |
| RENK GROUP | 1.792 |
| RHEINMETALL | 1.715 |
| TESLA | 1.308 |
| PALANTIR TECHNOLOGIES | 1.291 |
| VOLKSWAGEN | 1.271 |
| DEUTSCHE BANK | 1.155 |
| PLUG POWER | 1.081 |
| AMAZON | 1.050 |
| BYD | 1.048 |
| MICROSTRATEGY | 1.046 |
| PROSIEBENSAT.1 | 1.035 |
| BASF | 1.025 |
| COMMERZBANK | 1.023 |
| MERCEDES-BENZ | 954 |
| THYSSENKRUPP | 937 |
| JINKOSOLAR | 893 |
| ALLIANZ | 890 |
| AIXTRON SE | 886 |
| DEUTSCHE TELEKOM | 881 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
